What is a stem cell IV infusion?
A stem cell IV infusion involves administering a cellular biologic product intravenously, allowing the material to enter the circulation rather than being injected into one specific anatomical structure. This distinguishes IV treatment from the targeted regenerative procedures Dr. Shamloo offers for the joints, spine, and other tissues.
The specific characteristics of cellular products can vary substantially depending on their source, processing, composition, and intended use. For this reason, the term “stem cell therapy” does not describe one standardized treatment.
Dr. Shamloo evaluates the specific therapy, available evidence, regulatory considerations, and individual patient when discussing whether a cellular treatment is appropriate.
Targeted injection vs. IV infusion
The primary difference is where the regenerative treatment is delivered.
These treatments are not interchangeable, and the appropriate route depends on the therapy being considered, its intended purpose, available evidence, and the individual patient.
An evolving field of regenerative medicine
Cellular medicine is one of the most rapidly developing areas of biomedical research. Researchers continue to investigate how different cell populations interact with the body’s immune, inflammatory, repair, and signaling pathways, as well as their potential future applications across medicine.
However, it is important to distinguish scientific potential from established clinical benefit. Many stem cell-based products and uses marketed by regenerative clinics have not been approved by the FDA, and the FDA has reported serious adverse events associated with some unapproved regenerative products.
For that reason, Dr. Shamloo’s approach emphasizes medical evaluation, responsible patient selection, and transparency about what is — and is not — known about emerging cellular therapies.
IV therapy & longevity medicine
Interest in cellular medicine has grown alongside research into healthy aging, regenerative biology, and longevity.
For Dr. Shamloo, longevity medicine is not about promising to stop or reverse aging. It is about evaluating emerging medical technologies within a broader physician-directed strategy focused on health, function, recovery, and maintaining quality of life over time.
Stem cell-based IV therapies represent an emerging area within that larger field — but they should not be presented as a proven anti-aging treatment or cure for chronic disease.